Taylor Devlin | Revenue Accountant |
Phillip Chan | Chief Executive Officer |
Vincent Capponi | President and Chief Operating Officer |
Kathleen Bloch | Interim Chief Financial Officer |
Efthymios Deliargyris | Chief Medical Officer |
Christopher Cramer | Senior Vice President of Business Development |
Irina Kulinets | Senior Vice President of Regulatory |
Joshua Jennings | TD Cowen |
Laura Suriel | Alliance Global Partners |
Sean Lee | H.C. Wainwright |
Thomas Kerr | Zacks SCR |
Good afternoon and welcome to the Cytosorbents Second Quarter 2023 Financial and Operating Results Conference Call. At this time, all participants are in a listen-only mode.
Following the formal remarks, we will open the call for your questions. Please be advised that the call will be recorded at the company's request.
At this time, I'd like to turn the call over to our moderator, Taylor Devlin.